Atogepant Gains European Approval as Acute and Preventive Migraine TherapyByMarco MeglioJune 3rd 2026
Improving Access to Cognitive Screening in Multiple Sclerosis Care: Elizabeth S. Gromisch, PhD, MSCSByElizabeth S. Gromisch, PhD,Isabella Ciccone, MPHJune 3rd 2026
What Clinicians Need to Know About Emerging Stem Cell Therapies for Parkinson DiseaseByMarco Meglio,Claire Henchcliffe, MD, DPhil,Roger A. Barker, MD, PhDJune 3rd 2026
NeuroVoices: Rachel Kenney, PhD, on Integrating OCT Into the 2024 McDonald Criteria for Multiple SclerosisByRachel Kenney, PhD,Isabella Ciccone, MPHJune 3rd 2026
SKY-0515 Demonstrates Sustained Mutant Huntingtin Lowering in Latest Phase 1/2 Study UpdateByLouie PasculliJune 2nd 2026